Neuromuscular blocking drugs in the critically ill.
作者信息
Welhengama C, Hall A, Hunter J M
机构信息
St. Helen's and Knowsley Teaching Hospitals, Prescot, UK.
Liverpool University Foundation Trust, Liverpool, UK.
出版信息
BJA Educ. 2021 Jul;21(7):258-263. doi: 10.1016/j.bjae.2021.02.002. Epub 2021 Mar 19.
Abstract
摘要
相似文献
1
Neuromuscular blocking drugs in the critically ill.危重症患者使用的神经肌肉阻滞剂
BJA Educ. 2021 Jul;21(7):258-263. doi: 10.1016/j.bjae.2021.02.002. Epub 2021 Mar 19.
2
Use of neuromuscular blocking drugs in the critically ill patient.
Crit Care Clin. 1995 Oct;11(4):957-81.
3
Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: an executive summary. Society of Critical Care Medicine.成人重症患者持续神经肌肉阻滞的实践参数：执行摘要。危重病医学学会。
Crit Care Med. 1995 Sep;23(9):1601-5. doi: 10.1097/00003246-199509000-00022.
4
Neuromuscular-blocking drugs. Use and misuse in the intensive care unit.
Crit Care Clin. 2001 Oct;17(4):925-42. doi: 10.1016/s0749-0704(05)70187-1.
5
Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.成人危重症患者持续神经肌肉阻滞的临床实践指南。
Crit Care Med. 2016 Nov;44(11):2079-2103. doi: 10.1097/CCM.0000000000002027.
6
A review of neuromuscular blockade in the critically ill patient.
Dynamics. 2001 Fall;12(3):28-33; quiz 34-5.
7
Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents.
Crit Care Med. 1995 Mar;23(3):450-8. doi: 10.1097/00003246-199503000-00007.
8
Complications associated with sedative and neuromuscular blocking drugs in critically ill patients.危重症患者使用镇静药和神经肌肉阻滞剂相关的并发症。
Crit Care Clin. 1995 Oct;11(4):983-1003.
9
Neuromuscular blocking agents in the critically ill patient: neither sedating nor pain relieving.危重症患者使用的神经肌肉阻滞剂：既无镇静作用也无止痛作用。
AACN Clin Issues Crit Care Nurs. 1991 Nov;2(4):778-87. doi: 10.4037/15597768-1991-4017.
10
[Use of neuromuscular blockers in the critical patient].
Med Intensiva. 2008 Feb;32 Spec No. 1:69-76.
引用本文的文献
1
Neuromuscular Blocking Agents and Reversal Agents Usage, and Neuromuscular Blockade Monitoring in the Intensive Care Unit - Review Article.重症监护病房中神经肌肉阻滞剂及逆转剂的使用与神经肌肉阻滞监测——综述文章
Int J Gen Med. 2025 Jul 4;18:3651-3688. doi: 10.2147/IJGM.S524089. eCollection 2025.
2
The effect of sugammadex on postoperative urinary retention post-laparoscopic and robotic hysterectomy with and without concomitant procedures.研究表明，罗哌卡因复合舒更葡糖钠在剖宫产术后硬膜外自控镇痛中效果确切，不良反应少，值得临床推广应用。
Int Urogynecol J. 2024 May;35(5):1-7. doi: 10.1007/s00192-023-05668-1. Epub 2023 Nov 6.
3
A retrospective study of sugammadex for reversal of neuromuscular blockade induced by rocuronium in critically ill patients in the ICU.一项回顾性研究：ICU 危重症患者使用 sugammadex 逆转罗库溴铵诱导的神经肌肉阻滞。
Sci Rep. 2022 Jan 18;12(1):897. doi: 10.1038/s41598-022-04818-7.
本文引用的文献
1
Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.用于新型冠状病毒肺炎急性呼吸窘迫综合征的神经肌肉阻滞剂：一项多中心观察性研究
Crit Care. 2020 Jul 19;24(1):446. doi: 10.1186/s13054-020-03164-2.
2
ICU-acquired weakness.ICU 获得性肌无力
Intensive Care Med. 2020 Apr;46(4):637-653. doi: 10.1007/s00134-020-05944-4. Epub 2020 Feb 19.
3
Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials.急性呼吸窘迫综合征中神经肌肉阻滞剂使用的验证：一项随机试验的荟萃分析
Crit Care. 2020 Feb 17;24(1):54. doi: 10.1186/s13054-020-2765-2.
4
Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.急性呼吸窘迫综合征中的神经肌肉阻滞：随机对照试验的系统评价和荟萃分析
J Intensive Care. 2020 Jan 28;8:12. doi: 10.1186/s40560-020-0431-z. eCollection 2020.
5
Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis.急性呼吸窘迫综合征中的神经肌肉阻滞剂：荟萃分析。
PLoS One. 2020 Jan 21;15(1):e0227664. doi: 10.1371/journal.pone.0227664. eCollection 2020.
6
Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports.使用 sugammadex 治疗神经肌肉疾病患者：病例报告的系统评价。
BMC Anesthesiol. 2019 Nov 19;19(1):213. doi: 10.1186/s12871-019-0887-3.
7
Guidelines on the management of acute respiratory distress syndrome.急性呼吸窘迫综合征管理指南。
BMJ Open Respir Res. 2019 May 24;6(1):e000420. doi: 10.1136/bmjresp-2019-000420. eCollection 2019.
8
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征的早期神经肌肉阻滞。
N Engl J Med. 2019 May 23;380(21):1997-2008. doi: 10.1056/NEJMoa1901686. Epub 2019 May 19.
9
Early Paralytic Agents for ARDS? Yes, No, and Sometimes.用于急性呼吸窘迫综合征的早期麻痹药物？是，否，以及有时是。
N Engl J Med. 2019 May 23;380(21):2061-2063. doi: 10.1056/NEJMe1905627. Epub 2019 May 19.
10
Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.成人 ICU 患者疼痛、躁动/镇静、谵妄、活动减少、睡眠障碍预防与管理临床实践指南。
Crit Care Med. 2018 Sep;46(9):e825-e873. doi: 10.1097/CCM.0000000000003299.
Zotero 插件